雷米马佐拉姆 (Remimazolam) 是一种药物
Miguel T Teixeira1, Abhinav Goyal2
1Department of Anesthesiology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.
Advances in anesthesia
|October 23, 2024
概括
雷米马佐拉姆是一种新型的二,提供快速镇静和快速恢复,具有安全的特征. 其有利的药理动力学使其成为现有的静脉静止剂的有希望的替代品.
科学领域:
- 药理学 药理学是指药理学的学科.
- 麻醉学 麻醉学
- 临床药房 临床药房
背景情况:
- 静脉静止剂对于程序静止和麻醉至关重要.
- 现有的药物,如普罗波福和米达佐拉姆,在康复时间和心肺作用方面存在局限性.
- 需要具有更好的安全性和药理动力学特征的镇静剂.
研究的目的:
- 为了引入remimazolam,一种新的静脉静止剂.
- 为了突出其与其他镇静剂相比独特的特性.
- 讨论其潜在的临床应用.
主要方法:
- 雷米马佐拉姆是一种可逆的GABA-A激动剂,二胺.
- 它是静脉注射的.
- 评估其药理动力学和安全性概况.
主要成果:
- 雷米马佐拉姆显示出迅速开始起作用.
- 它提供了短时间的效果和快速恢复.
- 该药物表现出安全的心肺状况.
- 与其他静脉注射镇静剂相比,观察到有利的药理动力学.
结论:
- 雷米马佐拉姆在静脉静止时具有有利的安全性和药理动力学特征.
- 它的迅速发病和恢复使其成为临床实践中潜在的有价值的药物.
- 雷米马佐拉姆可能比现有的静脉静止剂具有优势.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149
REM Sleep Behavior Disorder
154
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
154
Sedatives and Hypnotics Drugs: Benzodiazepines
198
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
198
Management of Insomnia
234
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
234
Sedatives and Hypnotics: Overview
285
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
285
Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147


